Valuation (9%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -14.08 | -18.94 |
| PEG Ratio (TTM) | -0.14 | -5.61 |
| P/S Ratio (TTM) | 441.93 | 47.90 |
| P/B Ratio (TTM) | 5.88 | 30.89 |
| P/FCF Ratio (TTM) | -22.73 | -6.05 |
| Price to 5YR AVG Earnings Ratio | -16.29 | -5.69 |
| Price to 5YR AVG FCF Ratio | -37.01 | -13.62 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -32.16% | -17.89% |
| ROE (TTM) | -41.23% | 28.85% |
| Net Profit Margin (TTM) | -3,012.65% | -540.96% |
| ROIC 5YR AVG | -55.67% | -3.04% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -12.12% | -30,950.29% | -18,563.19% |
| Revenue | 157.74% | -31.10% | 1,192.20% |
| Net Income | -16.66% | -9.05% | -26.70% |
| Cash Flow | -21.63% | -69.39% | -61.29% |
Health (60%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 7.59 | 5.75 |
| Quick Ratio (TTM) | 7.59 | 5.53 |
| D/E Ratio (TTM) | 0.09 | 1.08 |
| Interest Coverage (TTM) | -25.78 | -7.40 |
| Piotroski F-Score | 3 | 5 |
| Altman Z-Score | 9.81 | 13.03 |
| LTL to 5YR AVG FCF | -0.47 | 0.08 |
| Shares Outstanding Growth 5YR AVG | 25.38% | 40.65% |